Case fatality risk of novel coronavirus diseases 2019 in China
Xiaowei Deng, Juan Yang, Wei Wang, Xiling Wang, Jiaxin Zhou, Zhiyuan Chen, Jing Li, Yinzi Chen, Han Yan, Juanjuan Zhang, Yongli Zhang, Yan Wang, Qi Qiu, Hui Gong, Xianglin Wei, Lili Wang, Kaiyuan Sun, Peng Wu, Marco Ajelli, Benjamin J. Cowling, Cecile Viboud, Hongjie Yu
doi: https://doi.org/10.1101/2020.03.04.20031005
Abstract
Objective The outbreak of novel coronavirus disease 2019 (COVID-19) imposed a substantial health burden in mainland China and remains a global epidemic threat. Our objectives are to assess the case fatality risk (CFR) among COVID-19 patients detected in mainland China, stratified by clinical category and age group. Method We collected individual information on laboratory-confirmed COVID-19 cases from publicly available official sources from December 29, 2019 to February 23, 2020. We explored the risk factors associated with mortality. We used methods accounting for right-censoring and survival analyses to estimate the CFR among detected cases.
*注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.